Quick Takeaways
- Andrew Cheng has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value is not available.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Andrew Cheng
- Location
- South San Francisco, CA
- Signature
- /s/ Jonathan Young, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Andrew Cheng and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Akero Therapeutics, Inc. ($0).
- Past-year value change for that position: -$9,638,932.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Andrew Cheng
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| AKRO | Akero Therapeutics, Inc. | President and CEO, Director | $0 | -$9,638,932 | -100% | 09 Dec 2025 |
| ABUS | Arbutus Biopharma Corp | Director | 03 Jun 2021 | |||
| VERA | Vera Therapeutics, Inc. | Director | 14 May 2025 |
Insider Transactions Reported by Andrew Cheng:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.